Oct. 2, 2009
Nektar Therapeutics Inc. will shift its headquarters and 150 employees to San Francisco after taking 102,283 square feet of office space in Mission Bay originally intended for Pfizer Inc.
The move from San Carlos is laced with a heavy dose of irony: Two years ago, Pfizer pulled the plug on a drug collaboration with Nektar, and nearly killed the company in the process.
It’s also laden with sizeable savings. Nektar will pay no rent in the first four years of the 10-year sublease deal and will snag a $15 million tenant improvement allowance granted to Pfizer by landlord Alexandria Real Estate Equities Inc.
Friday, October 30, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment